KKB Partner Suzan Onel will be moderating the panel, “FDA’s Breakthrough Devices Program and Safer Technologies Program (STeP): Strategies and Opportunities,” as part of the virtual Food and Drug Law Institute’s (FDLI’s) Annual Conference on May 18-20, 2021. This session will discuss the Breakthrough Devices program and the recently established STeP program, including the differences, benefits, and requirements of the two programs. She will be joined by panelists Maureen Dreher (FDA), Janice Hogan (Hogan Lovells), and Janet Michener Whipple (Validant).
Join us at the FDLI Annual Conference to hear from an array of experts as they address the complex legal, regulatory, compliance, and policy issues currently impacting all facets of FDA-regulated industry. Sign up with the discount code annual15 for 15% off registration: www.fdli.org/annual.